Beryl Drugs Ltd. benchmarking: Perfomance to industry peers

Financial

	Beryl Drugs	Shamrock Indl. Co	Rekvina Labs
Operational Metrics
Financials
5 yr Average ROE	3.64 %	-8.66 %	-118.34 %
5yr average Equity Multiplier	2.12	1.02	6.31
5yr Average Asset Turnover Ratio	1.19	0.0	0.0
5yr Avg Net Profit Margin	1.13 %	0.0	0.0
Price to Book	1.16	9.39	0.0
P/E	47.55	0.0	0.0
5yr Avg Cash Conversion Cycle	-589.78 Days	0.0	0.0
Inventory Days	36.09 Days	0.0	0.0
Days Receivable	112.55 Days	0.0	0.0
Days Payable	964.25 Days	0.0	0.0
5yr Average Interest Coverage Ratio	1.91	0.0	-132.32
5yr Avg ROCE	7.2 %	-8.65 %	-100.9 %
5yr Avg Operating Profit Margin	6.72 %	0.0	0.0
5 yr average Debt to Equity	0.59	0.0	-0.19
5yr CAGR Net Profit	19.3 %	-15.95 %	18.47 %
5yr Average Return on Assets	1.98 %	-8.47 %	-132.46 %
Shareholdings
Promoter Holding	26.38 %	43.36 %	41.3 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.46 %	0.38 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0